Supernus Pharmaceuticals
SUPN
$33.41
Share price
-0.51%
Change (1 day)
9.22%
Change (1 year)
Categories
Market capitalization of Supernus Pharmaceuticals (SUPN)
Market cap: $1.87 Billion USD
As of July 2025 Supernus Pharmaceuticals has a market cap of $1.87 Billion USD. This makes Supernus Pharmaceuticals the world's 4747th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Supernus Pharmaceuticals from 2012 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | $1.87 B | -8.89% |
| 2024 | $2.05 B | 29.85% |
| 2023 | $1.58 B | -18% |
| 2022 | $1.92 B | 24.34% |
| 2021 | $1.55 B | 16.58% |
| 2020 | $1.33 B | 6.75% |
| 2019 | $1.24 B | -28.3% |
| 2018 | $1.73 B | -14.92% |
| 2017 | $2.04 B | 63.31% |
| 2016 | $1.25 B | 89.92% |
| 2015 | $0.65 B | 84.65% |
| 2014 | $0.35 B | 18.31% |
| 2013 | $0.30 B | 37.31% |
| 2012 | $0.21 B |
End of Day market cap according to different sources
On Jul 28th, 2025 the market cap of Supernus Pharmaceuticals was reported to be:
$1.87 Billion USD
$1.87 Billion USD
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Zogenix ZGNX | $1.50 B | -19.80% | 🇺🇸 USA |
 United Therapeutics UTHR | $13.44 B | 618.91% | 🇺🇸 USA |
 Eli Lilly LLY | $729.58 B | 38,902.26% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $98.55 B | 5,168.81% | 🇺🇸 USA |
 Abbott Laboratories ABT | $219.82 B | 11,651.70% | 🇺🇸 USA |
 Johnson & Johnson JNJ | $400.31 B | 21,300.17% | 🇺🇸 USA |